Paris, France

Manuel Bedoya-Zurita


Average Co-Inventor Count = 4.7

ph-index = 1

Forward Citations = 9(Granted Patents)


Company Filing History:


Years Active: 1994-1995

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Manuel Bedoya-Zurita: Innovator in Chemical Synthesis

Introduction

Manuel Bedoya-Zurita is a prominent inventor based in Paris, France. He has made significant contributions to the field of chemical synthesis, particularly in the development of novel compounds with therapeutic applications. With a total of 3 patents to his name, his work continues to influence the industry.

Latest Patents

Among his latest patents, Manuel has focused on the preparation of derivatives of benzeneborinic acid. This includes the preparation and use of these derivatives as synthetic intermediates. Another notable patent involves 2-(tetrazol-5-yl)-1,1'-biphenyl derivatives, which are useful as intermediates in the synthesis of compounds possessing therapeutic activity. These innovations highlight his expertise in creating valuable chemical compounds.

Career Highlights

Manuel Bedoya-Zurita is currently associated with Synthelabo, a company known for its advancements in pharmaceutical research and development. His work at Synthelabo has allowed him to explore various chemical processes and contribute to the creation of new therapeutic agents.

Collaborations

Throughout his career, Manuel has collaborated with notable colleagues, including Isaac Chekroun and Jose Ruiz-Montes. These partnerships have fostered a collaborative environment that enhances innovation and research in their field.

Conclusion

Manuel Bedoya-Zurita stands out as a key figure in the realm of chemical synthesis, with a focus on developing compounds that have significant therapeutic potential. His contributions through patents and collaborations continue to shape the future of pharmaceutical research.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…